Nicolas Ouaritini-Benziane

Mougins, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?

Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?

Journal: International journal of radiation oncology, biology, physics

Published: April 15, 2025

Role of radiotherapy in the management of primary renal cell carcinoma: Recommendations from the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology).

Role of radiotherapy in the management of primary renal cell carcinoma: Recommendations from the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology).

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Published: November 24, 2024

Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate Cancer.

Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate Cancer.

Journal: European urology focus

Published: September 04, 2024

Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?

Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?

Journal: JAMA oncology

Published: August 08, 2024

Heart is a heavy burden: cardiac toxicity in radiation oncology.

Heart is a heavy burden: cardiac toxicity in radiation oncology.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 15, 2024

Dosimetric advantage of ipsilateral lung and cardiac sparing of left breast cancer prone position compared with supine free breathing in the COVID-19 era and personalized medicine.

Dosimetric advantage of ipsilateral lung and cardiac sparing of left breast cancer prone position compared with supine free breathing in the COVID-19 era and personalized medicine.

Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Published: February 16, 2024

Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol.

Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol.

Journal: European urology oncology

Published: February 14, 2024

Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU.

Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU.

Journal: The French journal of urology

Published: January 10, 2024

Emergency radiation therapy in modern-day practice: Now or never, or never again ?

Emergency radiation therapy in modern-day practice: Now or never, or never again ?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: August 09, 2023

Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.

Stereotactic body radiation therapy after radical prostatectomy: current status and future directions.

Journal: World journal of urology

Published: July 18, 2023

Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boost.

Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boost.

Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists

Published: April 07, 2023

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.

Journal: Cancers

Published: December 20, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026